These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7654753)

  • 1. Binding of antibodies to functional epitopes on the pore formed by Escherichia coli hemolysin in cells and model membranes.
    Menestrina G; Ropele M; Dalla Serra M; Pederzolli C; Hugo F; Pellet S; Welch RA
    Biochim Biophys Acta; 1995 Aug; 1238(1):72-80. PubMed ID: 7654753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of monoclonal antibodies against the Escherichia coli hemolysin.
    Pellett S; Boehm DF; Snyder IS; Rowe G; Welch RA
    Infect Immun; 1990 Mar; 58(3):822-7. PubMed ID: 1689701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pore-formation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family.
    Menestrina G; Moser C; Pellet S; Welch R
    Toxicology; 1994 Feb; 87(1-3):249-67. PubMed ID: 8160187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal antibodies against alpha-hemolysin of Escherichia coli.
    Oropeza-Wekerle RL; Kern P; Sun D; Muller S; Briand JP; Goebel W
    Infect Immun; 1991 May; 59(5):1846-52. PubMed ID: 1708360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prelytic and lytic conformations of erythrocyte-associated Escherichia coli hemolysin.
    Moayeri M; Welch RA
    Infect Immun; 1997 Jun; 65(6):2233-9. PubMed ID: 9169756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitopes of Escherichia coli alpha-hemolysin: identification of monoclonal antibodies that prevent hemolysis.
    Ji GE; O'Hanley P
    Infect Immun; 1990 Sep; 58(9):3029-35. PubMed ID: 1696938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes.
    Boehm DF; Welch RA; Snyder IS
    Infect Immun; 1990 Jun; 58(6):1959-64. PubMed ID: 2187815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of toxinogenic functions associated with the RTX repeat region and monoclonal antibody D12 epitope of Escherichia coli hemolysin.
    Rowe GE; Pellett S; Welch RA
    Infect Immun; 1994 Feb; 62(2):579-88. PubMed ID: 7507896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of calcium and other polyvalent cations on channel formation by Escherichia coli alpha-hemolysin in red blood cells and lipid bilayer membranes.
    Döbereiner A; Schmid A; Ludwig A; Goebel W; Benz R
    Eur J Biochem; 1996 Sep; 240(2):454-60. PubMed ID: 8841412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deletion of several amino acid stretches of Escherichia coli alpha-hemolysin (HlyA) suggests that the channel-forming domain contains beta-strands.
    Benz R; Maier E; Bauer S; Ludwig A
    PLoS One; 2014; 9(12):e112248. PubMed ID: 25463653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial hemolysins and leukotoxins affect target cells by forming large exogenous pores into their plasma membrane: Escherichia coli hemolysin A as a case example.
    Menestrina G; Dalla Serra M; Pederzolli C; Bregante M; Gambale F
    Biosci Rep; 1995 Dec; 15(6):543-51. PubMed ID: 9156583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes.
    Boehm DF; Welch RA; Snyder IS
    Infect Immun; 1990 Jun; 58(6):1951-8. PubMed ID: 2187814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine.
    O'Hanley P; Marcus R; Baek KH; Denich K; Ji GE
    Infect Immun; 1993 Mar; 61(3):1091-7. PubMed ID: 8432591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli.
    Ludwig A; Garcia F; Bauer S; Jarchau T; Benz R; Hoppe J; Goebel W
    J Bacteriol; 1996 Sep; 178(18):5422-30. PubMed ID: 8808931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli.
    Meysick KC; Mills M; O'Brien AD
    Infect Immun; 2001 Apr; 69(4):2066-74. PubMed ID: 11254559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycophorin as a receptor for Escherichia coli alpha-hemolysin in erythrocytes.
    Cortajarena AL; Goñi FM; Ostolaza H
    J Biol Chem; 2001 Apr; 276(16):12513-9. PubMed ID: 11134007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of fatty acid covalently bound to Escherichia coli alpha-hemolysin and membrane microdomains in the oligomerization process.
    Herlax V; Maté S; Rimoldi O; Bakás L
    J Biol Chem; 2009 Sep; 284(37):25199-210. PubMed ID: 19596862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes.
    Ludwig A; Jarchau T; Benz R; Goebel W
    Mol Gen Genet; 1988 Nov; 214(3):553-61. PubMed ID: 3063951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-dependent gating properties of the channel formed by E. coli hemolysin in planar lipid membranes.
    Menestrina G; Ropele M
    Biosci Rep; 1989 Aug; 9(4):465-73. PubMed ID: 2686776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorimetric assay for the effects of cytolytic toxins on the transport properties of resealed erythrocyte ghosts.
    Dalla Serra M; Pederzolli C; Menestrina G
    J Biochem Biophys Methods; 1992 Oct; 25(2-3):83-94. PubMed ID: 1491104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.